INS and Hyperinsulinemia: The prevalence of hyperinsulinemia (insulin ≥ 15 mU/mL) in the total sample was 6.52% (95% CI 4.35–9.65), being 8.41% (95% CI 4.54–15.09) and 5.87% (95% CI 3.49–9.72), in PVh and PoA, respectively—data not shown in the table.